Robert A. O’Reilly
Impact in
- Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism
- Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management
Papers in
- Pharmacology 40
- Pharmacogenetics and Drug Metabolism 39
-
- Atrial Fibrillation Management and Outcomes 14
- Co-authors
- Paul M. Aggeler (14 shared papers)Gerhard Levy (8 shared papers)William Trager (11 shared papers)Renpei Nagashima (2 shared papers)Milo Gibaldi (5 shared papers)Larry Heimark (4 shared papers)Kent L. Kunze (3 shared papers)David A. Stevens (1 shared paper)
- Journals
- Clinical Pharmacology & Therapeutics (14 papers)New England Journal of Medicine (6 papers)Journal of Clinical Investigation (5 papers)Journal of Pharmaceutical Sciences (5 papers)Annals of Internal Medicine (5 papers)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Robert A. O’Reilly
76 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 131
- Pharmacology 1.5k
- Internal Medicine 333
- Cardiology and Cardiovascular Medicine 788
- Pharmacology 458
- Toxicology 92
Countries citing papers authored by Robert A. O’Reilly
This map shows the geographic impact of Robert A. O’Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. O’Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. O’Reilly more than expected).
Fields of papers citing papers by Robert A. O’Reilly
This network shows the impact of papers produced by Robert A. O’Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. O’Reilly. The network helps show where Robert A. O’Reilly may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert A. O’Reilly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1967 | 180 | |
| 2 | 1976 | 179 | |
| 3 | 1982 | 175 | |
| 4 | 1969 | 171 | |
| 5 | 1963 | 169 | |
| 6 | 1970 | 159 | |
| 7 | 1968 | 158 | |
| 8 | 1992 | 131 | |
| 9 | 1986 | 118 | |
| 10 | 1964 | 98 | |
| 11 | Splenomegaly in 2,505 patients at a large university medical center from 1913 to 1995. 1963 to 1995: 449 patients. | 1998 | 97 |
| 12 | 1974 | 95 | |
| 13 | 1967 | 95 | |
| 14 | 1987 | 88 | |
| 15 | 1983 | 87 | |
| 16 | 1987 | 86 | |
| 17 | 1980 | 85 | |
| 18 | 1976 | 73 | |
| 19 | 1992 | 67 | |
| 20 | 1980 | 67 |
About Robert A. O’Reilly
Robert A. O’Reilly is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine, Nutrition and Dietetics, Molecular Biology and Analytical Chemistry, having authored 78 papers that have together received 4.0k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (39 papers), Atrial Fibrillation Management and Outcomes (14 papers), Vitamin K Research Studies (12 papers), Analytical Methods in Pharmaceuticals (11 papers), Hormonal Regulation and Hypertension (6 papers), Poisoning and overdose treatments (6 papers), Protein Interaction Studies and Fluorescence Analysis (5 papers) and Analytical Chemistry and Chromatography (5 papers). The work is most often cited by research in Pharmacology (1.5k citations), Internal Medicine (333 citations), Cardiology and Cardiovascular Medicine (788 citations), Pharmacology (458 citations) and Toxicology (92 citations). Robert A. O’Reilly has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Paul M. Aggeler, Gerhard Levy, William Trager, Renpei Nagashima, Milo Gibaldi, Larry Heimark, Kent L. Kunze, David A. Stevens, J N Galgiani and Richard DeFelice. Their work appears in journals such as Clinical Pharmacology & Therapeutics, New England Journal of Medicine, Journal of Clinical Investigation, Journal of Pharmaceutical Sciences and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.